Corcept Therapeutics (CORT) Earnings Analysis

Corcept Therapeutics (CORT) next reports earnings on 2026-07-30, consensus EPS 0.01227 USD. Last quarter (2026-04-30) it missed with EPS -0.3 USD vs -0.11019 USD est (-172.3%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 201.96.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CORT next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate0.01227 USD
Revenue estimate0.22B

CORT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-30-0.3 USD-0.11019 USD-172.3%Miss
2025-07-310.29 USD0.23 USD+26.1%Beat
2025-05-050.17 USD0.17 USD0%Beat
2025-02-260.26 USD0.37 USD-29.7%Miss
2024-10-300.41 USD0.28 USD+46.4%Beat
2024-07-290.32 USD0.23 USD+39.1%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

CORT valuation and analyst view

Trailing P/E201.96
Trailing EPS0.45869 USD
Price / book14.88
Dividend yield0.00%
Market cap10.01B
Analyst consensusBuy (14 buy / 10 hold / 2 sell)
Avg price target93 USD

Related research pages

Frequently asked questions

When is Corcept Therapeutics (CORT)'s next earnings date?

Corcept Therapeutics is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.01227 USD and revenue estimate of 0.22B.

Did CORT beat earnings last quarter?

In its 2026-04-30 report, CORT posted EPS of -0.3 USD versus a -0.11019 USD estimate — a miss of 172.3%.

What is CORT's earnings track record?

Over the last 6 reported quarters with consensus data, CORT beat estimates 4 times (67%).

What is CORT's current P/E ratio and EPS?

CORT trades at a trailing P/E of 201.96 on trailing EPS of 0.4586872217168574 USD.

What do analysts rate CORT?

Analyst consensus is "Buy" across 26 ratings (0 strong buy, 14 buy, 10 hold, 2 sell, 0 strong sell). Average 12-month price target: 93 USD.